dan 2163 has been researched along with Incipient Schizophrenia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmechtig, A | 2 |
Lees, J | 2 |
Grayson, L | 2 |
Craig, KJ | 2 |
Dadhiwala, R | 2 |
Dawson, GR | 2 |
Deakin, JF | 2 |
Dourish, CT | 2 |
Koychev, I | 2 |
McMullen, K | 2 |
Migo, EM | 1 |
Perry, C | 2 |
Wilkinson, L | 2 |
Morris, R | 1 |
Williams, SC | 1 |
Ettinger, U | 2 |
Walters, J | 1 |
Williams, S | 1 |
Barkus, E | 1 |
Ruhrmann, S | 1 |
Bechdolf, A | 1 |
Kühn, KU | 1 |
Wagner, M | 1 |
Schultze-Lutter, F | 1 |
Janssen, B | 1 |
Maurer, K | 1 |
Häfner, H | 1 |
Gaebel, W | 1 |
Möller, HJ | 1 |
Maier, W | 1 |
Klosterkötter, J | 1 |
3 trials available for dan 2163 and Incipient Schizophrenia
Article | Year |
---|---|
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Nic | 2013 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Fema | 2012 |
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Drug Administration | 2007 |